Vitamin C intake and breast cancer mortality in a cohort of Swedish women

British Journal of Cancer

Volumn 109, Issue 1, 2013, Pages 257-264

  Harris, H R ^a,b   Bergkvist, L ^c   Wolk, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; DRUG EFFECT; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; SWEDEN; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; ASCORBIC ACID; BREAST NEOPLASMS; DIET; DIETARY SUPPLEMENTS; FEMALE; FOOD PREFERENCES; HUMANS; MIDDLE AGED; QUESTIONNAIRES; SURVIVAL ANALYSIS; SWEDEN;

EID: 84880271722     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.269     Document Type: Article

References (44)

1. Bergström L, Kylberg E, Hagman U, Erikson H, Bruce A (1991) The food composition database KOST: the National Food Adminsitration's Information System for nutritive values of food. Vårö da 43: 439-447.
2. Cannizzo Elvira S, Clement Cristina C, Morozova K, Valdor R, Kaushik S, Almeida Larissa N, Follo C, Sahu R, Cuervo Ana M, Macian F, Santambrogio L (2012) Age-related oxidative stress compromises endosomal proteostasis. Cell Rep 2(1): 136-149.
3. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M (2008) Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. PNAS 105(32): 11105-11109.
4. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96(3): 218-228.
5. Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S (1979) Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. N Engl J Med 301(13): 687-690.
6. Cui Y, Shikany JM, Liu S, Shagufta Y, Rohan TE (2008) Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study. Am J Clin Nutr 87(4): 1009-1018.
7. D'Andrea GM (2005) Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55(5): 319-321.
8. Fleischauer AT, Simonsen N, Arab L (2003) Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women. Nutr Cancer 46(1): 15-22.
9. Frei B (1994) Reactive oxygen species and antioxidant vitamins: Mechanisms of action. Am J Med 97(3, Supplement 1): S5-S13.
10. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clinical Invest 114(12): 1752-1761.
11. Greenlee H, Hershman D, Jacobson J (2009) Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 115(3): 437-452.
12. Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, Weltzien E, Quesenberry CP, Caan BJ (2012) Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer 118(8): 2048-2058.
13. Hebert JR, Hurley TG, Ma Y (1998) The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat 51(1): 17-28.
14. Holmquist C, Larsson S, Wolk A, de Faire U (2003) Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women-Stockholm Heart Epidemiology Program (SHEEP). J Nutr 133(8): 2650-2654.
15. Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, Willett WC (1999) Dietary factors and the survival of women with breast carcinoma. Cancer 86(5): 826-835.
16. Huang W-Y, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151(7): 703-714.
17. Ingram D (1994) Diet and subsequent survival in women with breast cancer. Br J Cancer 69(3): 592-595.
18. Jain M, Miller AB, To T (1994) Premorbid diet and the prognosis of women with breast cancer. J Natl Cancer Inst 86(18): 1390-1397.
19. Keaney JF, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ (2003) Obesity and systemic oxidative stress. Arterioscler Thromb Vasc Biol 23(3): 434-439.
20. Larsson SC, Bergkvist L, Wolk A (2009) Long-term meat intake and risk of breast cancer by oestrogen and progesterone receptor status in a cohort of Swedish women. Eur J Cancer 45(17): 3042-3046.
21. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB (2008) Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100(11): 773-783.
22. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 93(8): 3704-3709.
23. Loo G (2003) Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation (review). J Nutr Biochem 14(2): 64-73.
24. Ludvigsson J, Otterblad-Olausson P, Pettersson B, Ekbom A (2009) The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24(11): 659-667.
25. Mattsson B, Wallgren A (1984) Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978.Acta Radiol Oncol 23: 305-313.
26. Maunsell E, Drolet M, Brisson J, Robert J, Deschênes L (2002) Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol 20(4): 1017-1025.
27. McEligot A, Largent J, Ziogas A, Peel D, Anton-Culver H (2006) Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer 55(2): 132-140.
28. Messerer M, Wolk A (2004) Sensitivity and specificity of self-reported use of dietary supplements. Eur J Clin Nutr 58(12): 1669-1671.
29. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM (1985) High-dose vitamin c versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. N Engl J Med 312(3): 137-141.
30. Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, Zheng W, Shu XO (2011) Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 20(2): 262-271.
31. Olusi S (2002) Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 26(9): 1159-1164.
32. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M (2004) Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Int Med 140(7): 533-537.
33. Rohan T, Hiller J, McMichael A (1993) Dietary factors and survival from breast cancer. Nutr Cancer 20(2): 167-177.
34. Salminen E, Bishop M, Poussa T, Drummond R, Salminen S (2004) Dietary attitudes and changes as well as use of supplements and complementary therapies by Australian and Finnish women following the diagnosis of breast cancer. Eur J Clin Nutr 58(1): 137-144.
35. Salminen EK, Lagstrom HK (2000) Does breast cancer change patients' dietary habits? Eur J Clin Nutr 54(11): 844-848.
36. Saquib J, Rock CL, Natarajan L, Saquib N, Newman VA, Patterson RE, Thomson CA, Al-Delaimy WK, Pierce JP (2011) Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer. Nutr Cancer 63(3): 327-333.
37. Saxe GA, Rock CL, Wicha MS, Schottenfeld D (1999) Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 53(3): 241-253.
38. Ullah M, Khan H, Zubair H, Shamim U, Hadi S (2011) The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer. Cancer Chemother Pharmacol 67(1): 103-110.
39. Velentzis L, Keshtgar M, Woodside J, Leathem A, Titcomb A, Perkins K, Mazurowska M, Anderson V, Wardell K, Cantwell M (2011) Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study. Breast Cancer Res Treat 128(2): 473-482.
40. Wayne SJ, Lopez ST, Butler LM, Baumgartner KB, Baumgartner RN, Ballard- Barbash R (2004) Changes in dietary intake after diagnosis of breast cancer. J Amer Diet Assoc 104(10): 1561-1568.
41. Willcox JK, Ash SL, Catignani GL (2004) Antioxidants and Prevention of Chronic Disease. Crit Rev Food Sci Nutr 44(4): 275-295.
42. Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124(1): 17-27.
43. Wolk A, Larsson SC, Johansson J-E, Ekman P (2006) Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA 296(11): 1371-1376.
44. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD (1995) Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa women's health study. Cancer 76(2): 275-283.